» Articles » PMID: 28924161

Molecular Mechanisms Involved in the Non-monotonic Effect of Bisphenol-a on Ca2+ Entry in Mouse Pancreatic β-cells

Overview
Journal Sci Rep
Specialty Science
Date 2017 Sep 20
PMID 28924161
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

In regulatory toxicology, the dose-response relationship is a key element towards fulfilling safety assessments and satisfying regulatory authorities. Conventionally, the larger the dose, the greater the response, following the dogma "the dose makes the poison". Many endocrine disrupting chemicals, including bisphenol-A (BPA), induce non-monotonic dose response (NMDR) relationships, which are unconventional and have tremendous implications in risk assessment. Although several molecular mechanisms have been proposed to explain NMDR relationships, they are largely undemonstrated. Using mouse pancreatic β-cells from wild-type and oestrogen receptor ERβ-/- mice, we found that exposure to increasing doses of BPA affected Ca entry in an NMDR manner. Low doses decreased plasma membrane Ca currents after downregulation of Cav2.3 ion channel expression, in a process involving ERβ. High doses decreased Ca currents through an ERβ-mediated mechanism and simultaneously increased Ca currents via oestrogen receptor ERα. The outcome of both molecular mechanisms explains the NMDR relationship between BPA and Ca entry in β-cells.

Citing Articles

Bisphenol F and Bisphenol S in a Complex Biomembrane: Comparison with Bisphenol A.

Villalain J J Xenobiot. 2024; 14(3):1201-1220.

PMID: 39311147 PMC: 11417855. DOI: 10.3390/jox14030068.


Interference with Systemic Negative Feedback Regulation as a Potential Mechanism for Nonmonotonic Dose-Responses of Endocrine-Disrupting Chemicals.

Shi Z, Xiao S, Zhang Q bioRxiv. 2024; .

PMID: 39282254 PMC: 11398479. DOI: 10.1101/2024.09.04.611257.


The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA).

Vom Saal F, Antoniou M, Belcher S, Bergman A, Bhandari R, Birnbaum L Environ Health Perspect. 2024; 132(4):45001.

PMID: 38592230 PMC: 11003459. DOI: 10.1289/EHP13812.


Invited Perspective: Closing the Loop of Nonmonotonicity-from Natural Hormones in Experimental Endocrinology to Endocrine Disruptors in Epidemiology.

Soto A, Sonnenschein C Environ Health Perspect. 2024; 132(2):21304.

PMID: 38415614 PMC: 10901106. DOI: 10.1289/EHP14499.


Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals.

Attema B, Kummu O, Pitkanen S, Weisell J, Vuorio T, Pennanen E Arch Toxicol. 2024; 98(3):911-928.

PMID: 38182912 PMC: 10861694. DOI: 10.1007/s00204-023-03658-2.


References
1.
Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A . The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect. 2006; 114(1):106-12. PMC: 1332664. DOI: 10.1289/ehp.8451. View

2.
Santos R, Rosario L, Nadal A, Garcia-Sancho J, Soria B, Valdeolmillos M . Widespread synchronous [Ca2+]i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch. 1991; 418(4):417-22. DOI: 10.1007/BF00550880. View

3.
Vandenberg L, Hauser R, Marcus M, Olea N, Welshons W . Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007; 24(2):139-77. DOI: 10.1016/j.reprotox.2007.07.010. View

4.
Vandenberg L, Colborn T, Hayes T, Heindel J, Jacobs Jr D, Lee D . Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012; 33(3):378-455. PMC: 3365860. DOI: 10.1210/er.2011-1050. View

5.
Quesada I, Fuentes E, Viso-Leon M, Soria B, Ripoll C, Nadal A . Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J. 2002; 16(12):1671-3. DOI: 10.1096/fj.02-0313fje. View